NCT04375566 is a clinical trial of Patient Decision Aid in Lung Cancer Stage I, sponsored by Maastricht University.

Who is sponsoring NCT04375566?

NCT04375566 is sponsored by Maastricht University.

What drugs are being tested in NCT04375566?

Interventions in NCT04375566: Patient Decision Aid.

What condition does NCT04375566 study?

NCT04375566 studies Lung Cancer Stage I, Lung Cancer Stage II.

Is NCT04375566 still recruiting?

NCT04375566 is currently status unknown. Last updated 25 August 2021.

Last reviewed 2021-08-25 · How we verify

NCT04375566

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Progressive Web App About Individualized Patient Decision Aid for NSCLC Stage I-II

Status unknown Last updated 25 August 2021

What this trial tests

trial testing Patient Decision Aid in Lung Cancer Stage I in 45 participants. Status unknown.

Timeline

4 October 2021

Primary endpoint
31 January 2022

28 February 2022

Quick facts

Lead sponsor	Maastricht University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	45
Start date	4 October 2021
Primary completion	31 January 2022
Estimated completion	28 February 2022
Sites	1 location across Netherlands

Drugs / interventions tested

Patient Decision Aid

Conditions studied

Lung Cancer Stage I — all drugs for Lung Cancer Stage I →
Lung Cancer Stage II — all drugs for Lung Cancer Stage II →

Sponsor

Maastricht University

Who can join

Adults 21 to 100, any sex, with Lung Cancer Stage I or Lung Cancer Stage II. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Studies indicate that the majority of early-stage non-small cell lung cancer (NSCLC) patients find it important to be involved in treatment decision making. However, in a recent study it has been reported that about 40% of the participants experienced decision conflict and feel uninformed(1). The investigators therefore developed a patient decision aid (PDA) for stage I-II NSCLC patients, that informs and empowers patients to help decide between stereotactic radiotherapy (SBRT) and surgery.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I-II non-small cell lung cancer.
Halilaj I, Ankolekar A, Lenaers A, Chatterjee A, et al · · 2023 · cited 2× · PMID 38586126 · DOI 10.3389/fdgth.2023.1303261

Verify or expand the search:

Other trials of Patient Decision Aid

Trials testing the same drug.

NCT07146152 — Empowering Women - Shared Decision Making in Managing Cervical Precancer · NA · not yet recruiting
NCT04357288 — Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation · NA · completed
NCT03568552 — Patient Decision Aid for Opioid Use Disorder · NA · completed
NCT04240717 — Shared Decision Making on Immunotherapy in Oncology · NA · completed
NCT03631758 — Evaluating the Impact of Evidence-based Information About Mammography on Breast Cancer Screening Decisions · NA · completed

Other recruiting trials for Lung Cancer Stage I

Currently open trials in the same condition.

NCT06424327 — A Registry for People With Lung Cancer · recruiting
NCT05832112 — Outside the Cage (OTC) Robotic Lobectomy · NA · active not recruiting
NCT05281237 — Avecure Flexible Microwave Ablation Probe For Lung Nodules · NA · recruiting

Other Maastricht University trials

Trials by the same sponsor.

NCT07417059 — Sex Hormones Impact on Cannabis Response · NA · recruiting
NCT07259005 — Breathe Hard to Breathe Easy: Online Breathwork-Assisted Therapy for Social Anxiety · NA · recruiting
NCT06914648 — The Dragon PLC Trial (DRAGON-PLC) · NA · recruiting
NCT07374926 — The Big Unknown: A Journey Into Generative AI's Transformative Effect on Medical Professions · NA · completed
NCT06031818 — Usability and Clinical Effectiveness of an Interpretable Deep Learning Framework for Post-Hepatectomy Liver Failure Pred · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04375566 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maastricht University
Last refreshed: 25 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04375566.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing